The Contract Network

Name: The Contract Network
Brand: The Contract Network

AI Native

AI-powered contract collaboration. All parties. One place. Get deals done fast.

Est 2021|Valuation $23M|Raised $11.8M

LinkedIn 1K|Website|FTEs 18|HQ Atlanta, Georgia, US

MarketsContract Negotiation Negotiation & Redlining Workflows

Published Sep 26, 2026

01Common complaints

1. Procurement requires abundant third-party reviews on platforms such as G2, Capterra, or TrustRadius; TCN has a limited footprint on those platforms. 2. Counterparties in your ecosystem will not adopt shared platforms; if the workflow remains entirely email-based, a collaboration network may not deliver ROI. 3. The buyer requires a comprehensive, enterprise-standard CLM across all departments and contract types immediately; large CLM suites may provide safer coverage for broad requirements. 4. The security team expects a public Trust Center with detailed attestations accessible prior to engagement; vendor documentation is limited in public sources. 5. Budget or procurement processes require transparent self-serve pricing; the vendor appears to be sales-led.

Deal disqualifiers (poor fit)

Organizations unable to persuade counterparties to use portals/tools
Teams seeking a lightweight eSignature-only tool
Regulated buyers that require publicly posted, extensive security documentation prior to running a pilot

Limitations acknowledged or implied by public materials

Pricing is not publicly disclosed.
Security documentation details are limited in public pages (SOC 2 is claimed but the supporting report/trust center details were not located).
Roadmap items referenced in public content lack firm public timelines.

Scale limitations

Not publicly documented. Buyers should request information on maximum file sizes, version counts, number of counterparty seats, performance SLAs, and uptime history.

API / integration constraints

Not publicly documented. Buyers should validate support and options for eSignature, document storage, identity (SSO/SAML), provisioning (SCIM), and domain-specific integrations (e.g., CTMS/eISF).

02Why they buy

Differentiators evidenced in vendor materials

Claimed neutral, shared collaboration model: the vendor states it does not take sides and positions the environment as a multi-party workspace.
Playbook-driven AI assistance: the platform describes AI-generated redlines based on configured playbooks and precedent comparisons.
Research-focused positioning: vendor materials emphasize the product's application to clinical research contracting and reference partnerships in that domain.

Where competitors have advantages

Independent validation (review volume, analyst coverage)
Broader CLM maturity and integrations
More transparent security documentation (varies by vendor)

Why customers chose TCN (inferred from positioning)

Based on messaging and partnerships, likely decision drivers include:

Need to reduce turnaround time on repeated agreement types (CTAs, NDAs, DPAs)
Interest in operationalizing negotiation knowledge via playbooks and precedent comparisons
Preference for a neutral multi-party workspace rather than a single-party CLM portal

03Field reports

Review platform availability (G2, Capterra, TrustRadius)

Searches did not locate clearly identifiable TCN product pages or reviews on major review platforms (G2, Capterra, TrustRadius) during this research.

Implication: there is limited third-party review volume available on typical vendor review sites; procurement teams should therefore rely more on vendor references, pilots, and security reviews.

Community/social discussion (Reddit, HackerNews)

Searches did not surface substantial Reddit or HackerNews threads specifically discussing TCN with user feedback.

Implication: there is limited publicly visible community traction; this can be common for early-stage, enterprise-focused products but reduces external validation.

Vendor-published testimonials and quotes

Vendor press materials include statements from partners and industry figures (for example, partner law firms and services partners). These statements provide directional signals but are not equivalent to independent user reviews. Example found in vendor materials: a partner law firm leader described the AI synthesis as instructive and educational, noting the usefulness of insights to client service. This quote appears in partner-focused materials and should be considered in context. Balance note: Without independent review platform data, this report cannot provide comparative star ratings or wide-sample user quotes from those platforms. The limited presence of independent reviews is an important market signal.

Why some customers might leave (inferred risks)

Potential churn drivers, inferred from category dynamics and vendor positioning, include:

Counterparties refusing to adopt a new portal/tool (network friction)
Variation in AI output quality depending on template and playbook maturity
Preference for an all-in-one CLM already deployed (e.g., Icertis, Ironclad, DocuSign CLM)

1) NDA analysis case study (M&A)

The vendor published an analysis of a large set of anonymized NDA negotiation points and reported that using market data up front could reduce a substantial portion of negotiation points. Critical evaluation: - The analysis was released by the vendor via press channels. Methodology details (sampling, anonymization method, selection bias, definition of "negotiation point," and reproducibility) were not publicly available in detail. - The study supports the thesis that NDA negotiations contain repetitive elements that may be susceptible to data-driven acceleration, but independent verification and methodological transparency are limited.

2) Clinical collaboration (clinical trial agreements)

The vendor announced a know-how agreement with a clinical institution to develop a solution aimed at accelerating clinical trial agreement negotiations. Critical evaluation: - The collaboration signals domain alignment and a partnership with a recognized clinical institution. - The announcement does not, by itself, demonstrate product usability or verified ROI at scale. Buyers should request measurable outcomes (cycle time reductions, quality metrics, stakeholder satisfaction) when evaluating such claims.

3) Partner solution: privacy contracting (DPAs)

A partner collaboration announcement claims reductions in time and cost for DPA markups.

Critical evaluation:

The claims are published jointly by vendor and partner; reported savings appear to reflect best-case or partner-specific metrics.
Buyers should verify baseline processes, measurement windows, the complexity distribution of DPAs included in the measurement, and whether savings persist after initial configuration.

04Best fit

Company sizes

Likely best fit:

Mid-market to enterprise organizations where contract cycle time materially affects revenue, study startup timelines, or deal throughput.
Organizations with dedicated contracting teams (legal ops, clinical ops contracting) and sufficient contract volume to justify playbook automation.

Industries / verticals

Healthcare & life sciences research (sites, sponsors, CRO-adjacent workflows)
Private markets / M&A advisory ecosystem (investment banks, PE firms, deal counsel) for NDA-heavy processes
Privacy/technology law workflows (DPAs) when delivered via partner integrations

Roles and personas

Decision makers: General Counsel, Head of Legal Ops, VP Clinical Operations, Procurement leadership
End users: contract managers, clinical trial agreement negotiators, paralegals, attorneys, deal teams

Qualification criteria (good fit)

High volume of similar agreements (CTAs, NDAs, DPAs)
Capacity to undertake workflow redesign and AI governance
Willingness to onboard counterparties into a shared collaboration model

05The pitch

What the product does (objective value proposition)

The Contract Network (TCN) is a B2B, AI-enabled contract collaboration platform designed to reduce negotiation cycle duration and to replace email + attachment workflows by providing a shared contracting environment for multiple parties (internal stakeholders and external counterparties). The platform is presented as neutral (not favoring either negotiating side) and focused on reducing negotiation cycle times and supporting post-signature compliance collaboration. Key capabilities described on the site include: - Automated assistance for redlines based on customer playbooks - Comparing new drafts to historical negotiated agreements to identify precedent and consistency - Playbook and standards compliance checks per revision - In-platform negotiation with the option to export for offline workflows - Signature and storage (searchable repository)

Target market and market positioning

TCN’s most prominent positioning is toward: - Clinical research contracting (clinical trial agreements and related research agreements). The vendor uses language describing research-focused, AI-related safeguards and cites collaboration with a recognized clinical institution in this vertical. - Private markets / M&A process contracting, initially emphasizing NDA workflows for middle-market transactions. - Adjacent specialized workflows such as privacy contracting (DPAs) via a law firm partner solution. Rather than broad, general-purpose CLM coverage, TCN appears positioned as: - A collaboration and negotiation acceleration layer - A platform with pre-configured playbooks for selected vertical use cases (notably research)

Get a comprehensive analysis of The Contract Network including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →

Published Sep 26, 2026

01Common complaints

Procurement requires abundant third-party reviews on platforms such as G2, Capterra, or TrustRadius; TCN has a limited footprint on those platforms.
Counterparties in your ecosystem will not adopt shared platforms; if the workflow remains entirely email-based, a collaboration network may not deliver ROI.
The buyer requires a comprehensive, enterprise-standard CLM across all departments and contract types immediately; large CLM suites may provide safer coverage for broad requirements.
The security team expects a public Trust Center with detailed attestations accessible prior to engagement; vendor documentation is limited in public sources.
Budget or procurement processes require transparent self-serve pricing; the vendor appears to be sales-led.

Deal disqualifiers (poor fit)

Organizations unable to persuade counterparties to use portals/tools
Teams seeking a lightweight eSignature-only tool
Regulated buyers that require publicly posted, extensive security documentation prior to running a pilot

Limitations acknowledged or implied by public materials

Pricing is not publicly disclosed.
Security documentation details are limited in public pages (SOC 2 is claimed but the supporting report/trust center details were not located).
Roadmap items referenced in public content lack firm public timelines.

Scale limitations

Not publicly documented. Buyers should request information on maximum file sizes, version counts, number of counterparty seats, performance SLAs, and uptime history.

API / integration constraints

Not publicly documented. Buyers should validate support and options for eSignature, document storage, identity (SSO/SAML), provisioning (SCIM), and domain-specific integrations (e.g., CTMS/eISF).

02Why they buy

Differentiators evidenced in vendor materials

Claimed neutral, shared collaboration model: the vendor states it does not take sides and positions the environment as a multi-party workspace.
Playbook-driven AI assistance: the platform describes AI-generated redlines based on configured playbooks and precedent comparisons.
Research-focused positioning: vendor materials emphasize the product's application to clinical research contracting and reference partnerships in that domain.

Where competitors have advantages

Independent validation (review volume, analyst coverage)
Broader CLM maturity and integrations
More transparent security documentation (varies by vendor)

Why customers chose TCN (inferred from positioning)

Based on messaging and partnerships, likely decision drivers include:

Need to reduce turnaround time on repeated agreement types (CTAs, NDAs, DPAs)
Interest in operationalizing negotiation knowledge via playbooks and precedent comparisons
Preference for a neutral multi-party workspace rather than a single-party CLM portal

03Field reports

Review platform availability (G2, Capterra, TrustRadius)

Searches did not locate clearly identifiable TCN product pages or reviews on major review platforms (G2, Capterra, TrustRadius) during this research.

Implication: there is limited third-party review volume available on typical vendor review sites; procurement teams should therefore rely more on vendor references, pilots, and security reviews.

Community/social discussion (Reddit, HackerNews)

Searches did not surface substantial Reddit or HackerNews threads specifically discussing TCN with user feedback.

Implication: there is limited publicly visible community traction; this can be common for early-stage, enterprise-focused products but reduces external validation.

Vendor-published testimonials and quotes

Example found in vendor materials: a partner law firm leader described the AI synthesis as instructive and educational, noting the usefulness of insights to client service. This quote appears in partner-focused materials and should be considered in context.

Balance note: Without independent review platform data, this report cannot provide comparative star ratings or wide-sample user quotes from those platforms. The limited presence of independent reviews is an important market signal.

Why some customers might leave (inferred risks)

Potential churn drivers, inferred from category dynamics and vendor positioning, include:

Counterparties refusing to adopt a new portal/tool (network friction)
Variation in AI output quality depending on template and playbook maturity
Preference for an all-in-one CLM already deployed (e.g., Icertis, Ironclad, DocuSign CLM)

1) NDA analysis case study (M&A)

The vendor published an analysis of a large set of anonymized NDA negotiation points and reported that using market data up front could reduce a substantial portion of negotiation points.

Critical evaluation:

The analysis was released by the vendor via press channels. Methodology details (sampling, anonymization method, selection bias, definition of "negotiation point," and reproducibility) were not publicly available in detail.
The study supports the thesis that NDA negotiations contain repetitive elements that may be susceptible to data-driven acceleration, but independent verification and methodological transparency are limited.

2) Clinical collaboration (clinical trial agreements)

The vendor announced a know-how agreement with a clinical institution to develop a solution aimed at accelerating clinical trial agreement negotiations.

Critical evaluation:

The collaboration signals domain alignment and a partnership with a recognized clinical institution.
The announcement does not, by itself, demonstrate product usability or verified ROI at scale. Buyers should request measurable outcomes (cycle time reductions, quality metrics, stakeholder satisfaction) when evaluating such claims.

3) Partner solution: privacy contracting (DPAs)

A partner collaboration announcement claims reductions in time and cost for DPA markups.

Critical evaluation:

The claims are published jointly by vendor and partner; reported savings appear to reflect best-case or partner-specific metrics.
Buyers should verify baseline processes, measurement windows, the complexity distribution of DPAs included in the measurement, and whether savings persist after initial configuration.

04Best fit

Company sizes

Likely best fit:

Mid-market to enterprise organizations where contract cycle time materially affects revenue, study startup timelines, or deal throughput.
Organizations with dedicated contracting teams (legal ops, clinical ops contracting) and sufficient contract volume to justify playbook automation.

Industries / verticals

Healthcare & life sciences research (sites, sponsors, CRO-adjacent workflows)
Private markets / M&A advisory ecosystem (investment banks, PE firms, deal counsel) for NDA-heavy processes
Privacy/technology law workflows (DPAs) when delivered via partner integrations

Roles and personas

Decision makers: General Counsel, Head of Legal Ops, VP Clinical Operations, Procurement leadership
End users: contract managers, clinical trial agreement negotiators, paralegals, attorneys, deal teams

Qualification criteria (good fit)

High volume of similar agreements (CTAs, NDAs, DPAs)
Capacity to undertake workflow redesign and AI governance
Willingness to onboard counterparties into a shared collaboration model

05The pitch

What the product does (objective value proposition)

Key capabilities described on the site include:

Automated assistance for redlines based on customer playbooks
Comparing new drafts to historical negotiated agreements to identify precedent and consistency
Playbook and standards compliance checks per revision
In-platform negotiation with the option to export for offline workflows
Signature and storage (searchable repository)

Target market and market positioning

TCN’s most prominent positioning is toward:

Clinical research contracting (clinical trial agreements and related research agreements). The vendor uses language describing research-focused, AI-related safeguards and cites collaboration with a recognized clinical institution in this vertical.
Private markets / M&A process contracting, initially emphasizing NDA workflows for middle-market transactions.
Adjacent specialized workflows such as privacy contracting (DPAs) via a law firm partner solution.

Rather than broad, general-purpose CLM coverage, TCN appears positioned as:

A collaboration and negotiation acceleration layer
A platform with pre-configured playbooks for selected vertical use cases (notably research)

Get a comprehensive analysis of The Contract Network including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →